Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2009
11/19/2009US20090286963 Antigenic fusion protein carrying gal alpha1,3gal epitopes
11/19/2009US20090286958 Interferon-beta fusion proteins and uses
11/19/2009US20090286861 Phenotypic reversion of pancreatic carcinoma cells
11/19/2009US20090286859 POTENT LNA OLIGONUCLEOTIDES FOR THE INHIBITION OF HIF-1a EXPRESSION
11/19/2009US20090286858 Assays for modulators of asparaginyl hydroxylase
11/19/2009US20090286857 Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
11/19/2009US20090286855 Interleukin-18 mutants, their production and use
11/19/2009US20090286854 Aptamers directed to muci
11/19/2009US20090286853 Modified oligonucleotides for telomerase inhibition
11/19/2009US20090286852 RNA containing modified nucleosides and methods of use thereof
11/19/2009US20090286851 Compositions and Methods for Delivering RNAI Using Lipoproteins
11/19/2009US20090286849 Modulation of insulin like growth factor i receptor expression
11/19/2009US20090286753 Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mrnas
11/19/2009US20090286742 polypeptides comprising amino acid sequences corresponding to, similar to or homologous to part of the amino acid sequence of neural thread proteins, used for treating unwanted cellular proliferations such as benign prostatatic hyperplasia, cancer, unwanted facial hair, warts and fatty tissues
11/19/2009US20090286736 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
11/19/2009US20090286733 Long-acting veterinary polypeptides and methods of producing and administering same
11/19/2009US20090286720 Pharmaceutical composition for the diagnosis, prevention or treatment of a tumoral pathology comprising an agent modulating the polymerization state of actin
11/19/2009US20090286714 Novel molecules of the card-related protein family and uses thereof
11/19/2009US20090286696 Double-Stranded Olidonucleotides and Uses Therefor
11/19/2009US20090286687 Method and Compositions for Detection and Enumeration of Genetic Variations
11/19/2009US20090286321 Methods for targeting modified raav vectors to mammalian cells
11/19/2009US20090286320 Site-specific recombination in eukaryotes and constructs useful therefor
11/19/2009US20090286319 Microinjection method and device
11/19/2009US20090286316 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
11/19/2009US20090286314 Fluorescent proteins and genes encoding them
11/19/2009US20090286313 Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
11/19/2009US20090286311 DNA sequences for the expression of alloproteins
11/19/2009US20090286294 Methods and Compositions for Improving the Production of Fuels in Microorganisms
11/19/2009US20090286291 Borrelidin-producing polyketide synthase and its use
11/19/2009US20090286288 ALPHA-1, 4-GALACTOSYLTRANSFERASE (CgtD) FROM CAMPYLOBACTER JEJUNI
11/19/2009US20090286287 METHODS AND COMPOSITIONS FOR USE IN PREPARRING siRNAs
11/19/2009US20090286285 Modified Nucleic Acid Polymers and Methods for their Production
11/19/2009US20090286283 Method and affinity column for purifying proteins
11/19/2009US20090286282 Method for Producing Antibody Fragments
11/19/2009US20090286281 Secretase for use in identifying modulator for treatment and prevention of alzheimers disease; Beta-site amyloid precursor protein cleaving enzyme (BACE)
11/19/2009US20090286265 Cripto Blocking Antibodies And Uses Thereof
11/19/2009US20090286262 Nucleic acid, polypeptide and its use
11/19/2009US20090286259 Screening method for gpcr ligands
11/19/2009US20090286254 Gene silencing
11/19/2009US20090286252 Nrif3, novel co-activator for nuclear hormone receptors
11/19/2009US20090286247 Novel nucleic acid base pair
11/19/2009US20090286244 Fluorescent Color Markers
11/19/2009US20090285968 Plants and seeds of spring canola variety scv384196
11/19/2009US20090285967 Plants and seeds of spring canola variety scv425044
11/19/2009US20090285933 Product and Process
11/19/2009US20090285932 Barley lipoxygenase 1 gene, method of selecting barley variety, material of malt alcoholic drinks and process for producing malt alcoholic drink
11/19/2009US20090285883 Identification of gastrointestinal, pancreatic and cancer stem cell markers and methods of use thereof
11/19/2009US20090285861 Tumor cell-based cancer immunotherapeutic compositions and methods
11/19/2009US20090285859 Allergenic proteins of natural rubber latex, their production and use in assays
11/19/2009US20090285855 Recombinant vaccine against japanese encephalitis virus (jev) infection and a method thereof
11/19/2009US20090285853 Nucleic Acids Encoding Respiratory Syncytial Virus Subgroup B strain 9320
11/19/2009US20090285852 Expression System Incorporating a Capsid Promotor Sequence as an Enhancer of a Cytomegalovirus Promotor
11/19/2009US20090285848 Methods and compositions for immunizing against pseudomonas infection
11/19/2009US20090285844 Non-toxic mutants of pathogenic gram-negative bacteria
11/19/2009US20090285843 Epitope sequences
11/19/2009US20090285825 Novel snake toxin
11/19/2009US20090285824 immunoglobulins; humanizing; chimera; fragments; complementary determining regions; breast cancer
11/19/2009US20090285822 Prevention and treatment of amyloidogenic disease
11/19/2009US20090285821 Campylobacter Pilus Protein, Compositions and Methods
11/19/2009US20090285818 Cripto Blocking Antibodies and Uses Thereof
11/19/2009US20090285817 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
11/19/2009US20090285816 Albumin Fusion Proteins
11/19/2009US20090285815 Immunoconjugates comprising cd4 and immunoglobin molecules for the treatment of hiv infection
11/19/2009US20090285814 CD 40 Binding Molecules and CTL Pepetides for Treating Tumors
11/19/2009US20090285809 Prevention and treatment of amyloidogenic diseases
11/19/2009US20090285807 Anti-Met Monoclonal Antibody, Fragments and Vectors Thereof, for the Treatment of Tumors and Corresponding Products
11/19/2009US20090285806 Methods and compositions for improving recombinant protein production
11/19/2009US20090285805 Binding molecules
11/19/2009US20090285803 ANTI-PirB ANTIBODIES
11/19/2009US20090285801 Calcium-Sensing Receptor 2 (CaR2) and Methods for Using
11/19/2009US20090285799 Antibody Antagonists of Interleukin-13 Receptor Alpha1
11/19/2009US20090285796 Mutant jak3 kinase in human leukemia
11/19/2009US20090285788 RANDOM RNAi LIBRARIES, METHODS OF GENERATING SAME, AND SCREENING METHODS UTILIZING SAME
11/19/2009US20090285783 Methods and compositions for cancer therapy using a novel adenovirus
11/19/2009US20090285771 Methods and compositions for needleless delivery of macromolecules
11/19/2009US20090285754 Peptides for targeting apoptotic cells and uses thereof
11/19/2009US20090285753 Novel haptotactic peptides
11/19/2009US20090285750 Agent, composition and method
11/19/2009DE102008029669A1 Neue Therapeutika für die Hepatitis-Therapie New therapeutics for the treatment of hepatitis
11/19/2009DE102008023447A1 New polypeptide having an amino acid position against the amino acid sequence, useful as human- or veterinary medicine and as disinfectant, and in food and cosmetics
11/19/2009CA2760041A1 Methods and compositions for the treatment of cancer
11/19/2009CA2725477A1 Methods for assessing colorectal cancer and compositions for use therein
11/19/2009CA2725468A1 Novel bacillus thuringiensis gene with lepidopteran activity
11/19/2009CA2724632A1 Asthma susceptibility loci located at chromosome 1q31 for use in diagnostic and therapeutic methods
11/19/2009CA2724596A1 Self-inactivating helper adenoviruses for the production of high-capacity recombinant adenoviruses
11/19/2009CA2724475A1 Genetic alterations on chromosomes 21q, 6q and 15q and methods of use thereof for the diagnosis and treatment of type i diabetes
11/19/2009CA2724343A1 Methods and reagents for detecting cpg methylation with a methyl cpg binding protein (mbp)
11/19/2009CA2724304A1 Improved yeast strain for production of four carbon alcohols
11/19/2009CA2724250A1 Chimeric compositions and methods for regulating plant gene expression
11/19/2009CA2724220A1 Microanalysis chip adhesive sheet, microanalysis chip, and manufacturing method thereof
11/19/2009CA2724198A1 Novel and powerful mhc-class ii petptides derived from survivin
11/19/2009CA2724179A1 Oligonucleotides for treating inflammation and neoplastic cell proliferation
11/19/2009CA2724105A1 Diblock copolymers and polynucleotide complexes thereof for delivery into cells
11/19/2009CA2724076A1 Heterologous expression of fungal cellobiohydrolases in yeast
11/19/2009CA2724052A1 Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
11/19/2009CA2724014A1 Micellic assemblies
11/19/2009CA2723968A1 Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
11/19/2009CA2723726A1 Inactivatable target capture oligomers for use in the selective hybridization and capture of target nucleic acid sequences
11/19/2009CA2723595A1 Electroporation of adherent cells with an array of closely spaced electrodes
11/19/2009CA2723242A1 Gene synthesis by convergent assembly of oligonucleotide subsets